Anti CD20-based immunochemotherapy abolishes antibody response to Covid-19 mRNA vaccine in lymphoma patients vaccinated during active first line treatment.
Silvia BellesiMichela SaliElena MaioloMaria Del Carmen Pereyra BozaEleonora AlmaIvana PalucciFederica FatoneFlavio De MaioMarcello ViscovoFrancesco D'AlòValerio De StefanoStefan HohausSanguinetti MaurizioPublished in: Leukemia & lymphoma (2022)